3632 results for «996»
3632 results
LAA closure
09 Feb 2025 – From PCR Tokyo Valves 2025
This session offers valuable insights into various aspects of left atrial appendage (LAA) closure, a critical procedure for stroke prevention in atrial fibrillation patients. Explore improvements to the safety checklist, case studies on left atrial thrombosis and mobile thrombus management, as well as a successful case...
Coronary access after TAVI: timing and techniques
09 Feb 2025 – From PCR Tokyo Valves 2025
Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:
- Case 1: Managing a patient with...
Expanding indications for TAVI - moderate aortic stenosis and heart failure
09 Feb 2025 – From PCR Tokyo Valves 2025
Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.
You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...
Complex anatomical features
09 Feb 2025 – From PCR Tokyo Valves 2025
Dive into a captivating session that explores complex anatomical features in interventional cardiology. Discover dynamic improvements in tricuspid valve coaptation and regurgitation post-TAVI, the overlooked threat of aortic stenosis hidden by mitral stenosis, marked improvement in left ventricular function after simultaneous TAVI and M-TEER, recognition of...
Challenging TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this captivating session that explores challenging TAVI procedures. Witness the management of a patient with pure aortic regurgitation and previous mitral valve replacement, an extremely challenging transfemoral TAVI, the management of bradycardia before TAVI in a patient with MVR and TVR, a case of...
TAV-in-SAV - Part 2
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the second part of the TAV-in-SAV session, where you'll discover the reproducible BASILICA technique using an enface view, chimney stenting during TAV-in-SAV in a high coronary occlusion risk patient, urgent zero contrast TAV-in-SAV, a tale of a complication where you shouldn't BASILICA the new...
Valve in valve in small degenerative surgical bioprosthesis - LIVE case
09 Feb 2025 – From PCR Tokyo Valves 2025
A 74-year-old female with a permanent pacemaker and preserved LV function presented with a symptomatic degenerative surgical valve (SJ Epic 21) implanted in 2016.
Patient underwent implantation of an Evolut FX 26 mm under general anesthesia with cerebral embolic protection and TEE guidance. A surgical valve fracture...
M-TEER for challenging anatomy
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of M-TEER for challenging anatomies. Understand the types of complex anatomies, the associated risks of complications, and learn how to select the appropriate TEER strategy for patients with small left atria, large gaps, and giant left atria. Gain valuable insights to optimize...
Concept medical announces preliminary 3-year SIRONA data at Charing Cross Symposium 2026
21 Apr 2026
TAILORED-CHIP: Tailored antiplatelet therapy for complex high-risk PCI
29 Aug 2025
Nicola Ryan provides her take on the results of TAILORED-CHIP presented by Duk-Woo Park at the ESC Congress 2025 in Madrid.
Author
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
